|
業務類別
|
Medical Devices |
|
業務概覽
|
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States. |
| 公司地址
| 44 3rd Avenue, Burlington, MA, USA, 01803 |
| 電話號碼
| +1 857 254-1500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.908devices.com |
| 員工數量
| 172 |
| Mr. Joseph H. Griffith,IV |
Chief Financial Officer, Principal Accounting Officer and Treasurer |
美元 378.35K |
29/04/2026 |
| Mr. Mark S. Levine |
Chief Legal and Administrative Officer and Secretary |
-- |
29/04/2026 |
| Dr. Kevin J. Knopp, PhD |
President, Chief Executive Officer and Director |
美元 500.00K |
29/04/2026 |
| Dr. Kevin J. McCallion, PhD |
Senior Vice President, Products and Production |
-- |
29/04/2026 |
| Mr. John Kenneweg |
Senior Vice President, Sales and Product Marketing |
-- |
29/04/2026 |
| Mr. Kolawole A. Otitoju |
Chief Business and Strategy Officer |
-- |
29/04/2026 |
| Mr. Christopher D. Brown, PhD |
Independent Director |
-- |
29/04/2026 |
|
|
| Mr. Fenel M. Eloi |
Independent Director |
29/04/2026 |
| Mr. Keith L. Crandell |
Independent Director |
29/04/2026 |
| Mr. E. Kevin Hrusovsky |
Chairman of the Board |
29/04/2026 |
| Dr. Brandi C. Vann, PhD |
Independent Director |
29/04/2026 |
| Ms. Michele M. Leonhart |
Independent Director |
29/04/2026 |
| Mr. Tony J. Hunt |
Independent Director |
29/04/2026 |
| Dr. Kevin J. Knopp, PhD |
President, Chief Executive Officer and Director |
29/04/2026 |
| Mr. Mark Spoto |
Independent Director |
29/04/2026 |
| Mr. Christopher D. Brown, PhD |
Independent Director |
29/04/2026 |
|
|
|
|
